Institute for Global Health and Infectious Diseases (IGHID) 11911 - Cross-reactive N. Gonorrhoeae Immune Responses Induced by a N. Meningitidis Vaccine
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Meningococcal vaccine group B OMV Novartis (Primary)
- Indications Meningococcal group B infections
- Focus Pharmacodynamics
Most Recent Events
- 12 Mar 2021 Status changed from recruiting to completed.
- 17 Aug 2020 Planned End Date changed from 1 Dec 2020 to 1 Feb 2021.
- 17 Aug 2020 Planned primary completion date changed from 1 Sep 2020 to 1 Feb 2021.